Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - gemcitabine hydrochloride, quantity: 1700 mg - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine sun 10mg/ml solution for infusion is also indicated for patients with 5-fu refractory pancreatic cancer. gemcitabine sun 10mg/ml solution for infusion, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. gemcitabine sun 10mg/ml solution for infusion, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. gemcitabine sun 10mg/ml solution for infusion, in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum-based therapy.

India - English - Central Drugs Standard Control Organization

warren - chlorhexidine gluconate - mouthwash - 0.2%w/v - 50ml/100ml/170ml

New Zealand - English - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - alginic acid 500mg; aluminium hydroxide gel dried 100mg; magnesium trisilicate hydrate 25mg; sodium bicarbonate 170mg - tablet - 500/100/25/170mg - active: alginic acid 500mg aluminium hydroxide gel dried 100mg magnesium trisilicate hydrate 25mg sodium bicarbonate 170mg

New Zealand - English - Medsafe (Medicines Safety Authority)

reckitt benckiser (new zealand) limited - alginic acid 500mg; aluminium hydroxide gel dried 100mg; magnesium trisilicate hydrate 25mg; sodium bicarbonate 170mg - chewable tablet - 500/100/25/170mg - active: alginic acid 500mg aluminium hydroxide gel dried 100mg magnesium trisilicate hydrate 25mg sodium bicarbonate 170mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

saneca pharmaceuticals. a.s. - oleum pini silvestris, oleum eucalypti, thymol, tocopherol acetate, oleum menthae piperitae, guaiazulene - drops nasal - 375,2mg/10ml+50mg/10ml+3,2mg/10ml+170mg/10ml+100mg/10ml+2mg/10ml

Malta - English - Medicines Authority

sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - oxybutynin hydrochloride - tablet - oxybutynin hydrochloride 5 mg - urologicals

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - oxybutynin hydrochloride - oral tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - alfuzosin hydrochloride - oral tablet - 2.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - oxybutynin hydrochloride - oral tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - alfuzosin hydrochloride - oral tablet - 2.5mg